Global CRO in Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 118
Published Date: 19 Nov 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global CRO in Clinical Trials market size was valued at US$ 48580 million in 2023 and is forecast to a readjusted size of USD 89680 million by 2030 with a CAGR of 9.3% during review period.
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%. In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.
The market for Contract Research Organizations (CROs) in clinical trials is experiencing significant growth and evolution due to various factors:
Biopharmaceutical Companies: Many pharma and biotech firms are increasingly outsourcing clinical trials to CROs to reduce costs, improve efficiency, and tap into specialized expertise. This trend is particularly notable among smaller biotech companies with limited infrastructure.
Focus on Core Competencies: Large pharmaceutical companies prefer focusing on core R&D activities, delegating clinical trial processes to CROs for scalability and cost-effectiveness.
Decentralized Clinical Trials (DCTs): CROs are innovating with decentralized trial models, enabling remote patient monitoring and data collection. This trend has accelerated post-COVID-19, enhancing patient recruitment, retention, and trial accessibility.
Adaptive and Hybrid Trials: The need for quicker, adaptable trials that can respond to real-time data is driving hybrid and adaptive trial designs. CROs are investing in capabilities to support these complex trial models.
Expanding Trials in APAC and LATAM: CROs are increasingly establishing operations in Asia-Pacific, Latin America, and Eastern Europe, where costs are lower, and recruitment pools are larger.
Regulatory Alignment: Many countries are harmonizing their regulatory requirements with global standards, making it easier for CROs to conduct trials internationally.
Artificial Intelligence (AI) and Machine Learning (ML): CROs are adopting AI/ML for predictive modeling, patient recruitment, trial monitoring, and data analysis, increasing accuracy and efficiency.
Digital Health Technologies: Wearable devices and digital health tools for real-time data capture are becoming integral in trials, supporting both remote and hybrid trial models.
Specialized Trials: Growth in oncology and rare disease research, which often require specialized trial designs and complex patient recruitment, is pushing CROs to develop niche expertise.
Patient-Centric Approaches: CROs are focusing on patient-centric methods to enhance participation and retention, especially in studies with rare or hard-to-reach patient populations.
Compliance and Quality Control: As regulations become more stringent, CROs are enhancing their quality assurance programs to ensure compliance with Good Clinical Practice (GCP) and international standards.
Data Security and Privacy: CROs are also adapting to increased demands for data privacy, especially with the rise in remote and decentralized trials.
This report is a detailed and comprehensive analysis for global CRO in Clinical Trials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CRO in Clinical Trials market size and forecasts, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRO in Clinical Trials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRO in Clinical Trials market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRO in Clinical Trials market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
CRO in Clinical Trials market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Market segment by Application
Pharmaceutical
Bio-pharm
Others
Market segment by players, this report covers
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
Medpace Holdings
Wuxi Apptec
Tigermed
Boji Medical Technology
Pharmaron
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRO in Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRO in Clinical Trials, with revenue, gross margin, and global market share of CRO in Clinical Trials from 2019 to 2024.
Chapter 3, the CRO in Clinical Trials competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRO in Clinical Trials market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRO in Clinical Trials.
Chapter 13, to describe CRO in Clinical Trials research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CRO in Clinical Trials by Type
1.3.1 Overview: Global CRO in Clinical Trials Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CRO in Clinical Trials Consumption Value Market Share by Type in 2023
1.3.3 Phase I Trial
1.3.4 Phase II Trial
1.3.5 Phase III Trial
1.3.6 Phase IV Trial
1.4 Global CRO in Clinical Trials Market by Application
1.4.1 Overview: Global CRO in Clinical Trials Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Bio-pharm
1.4.4 Others
1.5 Global CRO in Clinical Trials Market Size & Forecast
1.6 Global CRO in Clinical Trials Market Size and Forecast by Region
1.6.1 Global CRO in Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CRO in Clinical Trials Market Size by Region, (2019-2030)
1.6.3 North America CRO in Clinical Trials Market Size and Prospect (2019-2030)
1.6.4 Europe CRO in Clinical Trials Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CRO in Clinical Trials Market Size and Prospect (2019-2030)
1.6.6 South America CRO in Clinical Trials Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa CRO in Clinical Trials Market Size and Prospect (2019-2030)
2.1 Labcorp
2.1.1 Labcorp Details
2.1.2 Labcorp Major Business
2.1.3 Labcorp CRO in Clinical Trials Product and Solutions
2.1.4 Labcorp CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Labcorp Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA CRO in Clinical Trials Product and Solutions
2.2.4 IQVIA CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 Parexel
2.3.1 Parexel Details
2.3.2 Parexel Major Business
2.3.3 Parexel CRO in Clinical Trials Product and Solutions
2.3.4 Parexel CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Parexel Recent Developments and Future Plans
2.4 Syneos Health
2.4.1 Syneos Health Details
2.4.2 Syneos Health Major Business
2.4.3 Syneos Health CRO in Clinical Trials Product and Solutions
2.4.4 Syneos Health CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Syneos Health Recent Developments and Future Plans
2.5 PRA Health Sciences
2.5.1 PRA Health Sciences Details
2.5.2 PRA Health Sciences Major Business
2.5.3 PRA Health Sciences CRO in Clinical Trials Product and Solutions
2.5.4 PRA Health Sciences CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 PRA Health Sciences Recent Developments and Future Plans
2.6 PPD
2.6.1 PPD Details
2.6.2 PPD Major Business
2.6.3 PPD CRO in Clinical Trials Product and Solutions
2.6.4 PPD CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 PPD Recent Developments and Future Plans
2.7 ICON
2.7.1 ICON Details
2.7.2 ICON Major Business
2.7.3 ICON CRO in Clinical Trials Product and Solutions
2.7.4 ICON CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 ICON Recent Developments and Future Plans
2.8 Medpace Holdings
2.8.1 Medpace Holdings Details
2.8.2 Medpace Holdings Major Business
2.8.3 Medpace Holdings CRO in Clinical Trials Product and Solutions
2.8.4 Medpace Holdings CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Medpace Holdings Recent Developments and Future Plans
2.9 Wuxi Apptec
2.9.1 Wuxi Apptec Details
2.9.2 Wuxi Apptec Major Business
2.9.3 Wuxi Apptec CRO in Clinical Trials Product and Solutions
2.9.4 Wuxi Apptec CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wuxi Apptec Recent Developments and Future Plans
2.10 Tigermed
2.10.1 Tigermed Details
2.10.2 Tigermed Major Business
2.10.3 Tigermed CRO in Clinical Trials Product and Solutions
2.10.4 Tigermed CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tigermed Recent Developments and Future Plans
2.11 Boji Medical Technology
2.11.1 Boji Medical Technology Details
2.11.2 Boji Medical Technology Major Business
2.11.3 Boji Medical Technology CRO in Clinical Trials Product and Solutions
2.11.4 Boji Medical Technology CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Boji Medical Technology Recent Developments and Future Plans
2.12 Pharmaron
2.12.1 Pharmaron Details
2.12.2 Pharmaron Major Business
2.12.3 Pharmaron CRO in Clinical Trials Product and Solutions
2.12.4 Pharmaron CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Pharmaron Recent Developments and Future Plans
3.1 Global CRO in Clinical Trials Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CRO in Clinical Trials by Company Revenue
3.2.2 Top 3 CRO in Clinical Trials Players Market Share in 2023
3.2.3 Top 6 CRO in Clinical Trials Players Market Share in 2023
3.3 CRO in Clinical Trials Market: Overall Company Footprint Analysis
3.3.1 CRO in Clinical Trials Market: Region Footprint
3.3.2 CRO in Clinical Trials Market: Company Product Type Footprint
3.3.3 CRO in Clinical Trials Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global CRO in Clinical Trials Consumption Value and Market Share by Type (2019-2024)
4.2 Global CRO in Clinical Trials Market Forecast by Type (2025-2030)
5.1 Global CRO in Clinical Trials Consumption Value Market Share by Application (2019-2024)
5.2 Global CRO in Clinical Trials Market Forecast by Application (2025-2030)
6.1 North America CRO in Clinical Trials Consumption Value by Type (2019-2030)
6.2 North America CRO in Clinical Trials Market Size by Application (2019-2030)
6.3 North America CRO in Clinical Trials Market Size by Country
6.3.1 North America CRO in Clinical Trials Consumption Value by Country (2019-2030)
6.3.2 United States CRO in Clinical Trials Market Size and Forecast (2019-2030)
6.3.3 Canada CRO in Clinical Trials Market Size and Forecast (2019-2030)
6.3.4 Mexico CRO in Clinical Trials Market Size and Forecast (2019-2030)
7.1 Europe CRO in Clinical Trials Consumption Value by Type (2019-2030)
7.2 Europe CRO in Clinical Trials Consumption Value by Application (2019-2030)
7.3 Europe CRO in Clinical Trials Market Size by Country
7.3.1 Europe CRO in Clinical Trials Consumption Value by Country (2019-2030)
7.3.2 Germany CRO in Clinical Trials Market Size and Forecast (2019-2030)
7.3.3 France CRO in Clinical Trials Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CRO in Clinical Trials Market Size and Forecast (2019-2030)
7.3.5 Russia CRO in Clinical Trials Market Size and Forecast (2019-2030)
7.3.6 Italy CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region
8.3.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2019-2030)
8.3.2 China CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.3.3 Japan CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.3.4 South Korea CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.3.5 India CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CRO in Clinical Trials Market Size and Forecast (2019-2030)
8.3.7 Australia CRO in Clinical Trials Market Size and Forecast (2019-2030)
9.1 South America CRO in Clinical Trials Consumption Value by Type (2019-2030)
9.2 South America CRO in Clinical Trials Consumption Value by Application (2019-2030)
9.3 South America CRO in Clinical Trials Market Size by Country
9.3.1 South America CRO in Clinical Trials Consumption Value by Country (2019-2030)
9.3.2 Brazil CRO in Clinical Trials Market Size and Forecast (2019-2030)
9.3.3 Argentina CRO in Clinical Trials Market Size and Forecast (2019-2030)
10.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country
10.3.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2019-2030)
10.3.2 Turkey CRO in Clinical Trials Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CRO in Clinical Trials Market Size and Forecast (2019-2030)
10.3.4 UAE CRO in Clinical Trials Market Size and Forecast (2019-2030)
11.1 CRO in Clinical Trials Market Drivers
11.2 CRO in Clinical Trials Market Restraints
11.3 CRO in Clinical Trials Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 CRO in Clinical Trials Industry Chain
12.2 CRO in Clinical Trials Upstream Analysis
12.3 CRO in Clinical Trials Midstream Analysis
12.4 CRO in Clinical Trials Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global CRO in Clinical Trials Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global CRO in Clinical Trials Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global CRO in Clinical Trials Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global CRO in Clinical Trials Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Labcorp Company Information, Head Office, and Major Competitors
Table 6. Labcorp Major Business
Table 7. Labcorp CRO in Clinical Trials Product and Solutions
Table 8. Labcorp CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Labcorp Recent Developments and Future Plans
Table 10. IQVIA Company Information, Head Office, and Major Competitors
Table 11. IQVIA Major Business
Table 12. IQVIA CRO in Clinical Trials Product and Solutions
Table 13. IQVIA CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. IQVIA Recent Developments and Future Plans
Table 15. Parexel Company Information, Head Office, and Major Competitors
Table 16. Parexel Major Business
Table 17. Parexel CRO in Clinical Trials Product and Solutions
Table 18. Parexel CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Syneos Health Company Information, Head Office, and Major Competitors
Table 20. Syneos Health Major Business
Table 21. Syneos Health CRO in Clinical Trials Product and Solutions
Table 22. Syneos Health CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. Syneos Health Recent Developments and Future Plans
Table 24. PRA Health Sciences Company Information, Head Office, and Major Competitors
Table 25. PRA Health Sciences Major Business
Table 26. PRA Health Sciences CRO in Clinical Trials Product and Solutions
Table 27. PRA Health Sciences CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. PRA Health Sciences Recent Developments and Future Plans
Table 29. PPD Company Information, Head Office, and Major Competitors
Table 30. PPD Major Business
Table 31. PPD CRO in Clinical Trials Product and Solutions
Table 32. PPD CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. PPD Recent Developments and Future Plans
Table 34. ICON Company Information, Head Office, and Major Competitors
Table 35. ICON Major Business
Table 36. ICON CRO in Clinical Trials Product and Solutions
Table 37. ICON CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. ICON Recent Developments and Future Plans
Table 39. Medpace Holdings Company Information, Head Office, and Major Competitors
Table 40. Medpace Holdings Major Business
Table 41. Medpace Holdings CRO in Clinical Trials Product and Solutions
Table 42. Medpace Holdings CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Medpace Holdings Recent Developments and Future Plans
Table 44. Wuxi Apptec Company Information, Head Office, and Major Competitors
Table 45. Wuxi Apptec Major Business
Table 46. Wuxi Apptec CRO in Clinical Trials Product and Solutions
Table 47. Wuxi Apptec CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Wuxi Apptec Recent Developments and Future Plans
Table 49. Tigermed Company Information, Head Office, and Major Competitors
Table 50. Tigermed Major Business
Table 51. Tigermed CRO in Clinical Trials Product and Solutions
Table 52. Tigermed CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Tigermed Recent Developments and Future Plans
Table 54. Boji Medical Technology Company Information, Head Office, and Major Competitors
Table 55. Boji Medical Technology Major Business
Table 56. Boji Medical Technology CRO in Clinical Trials Product and Solutions
Table 57. Boji Medical Technology CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Boji Medical Technology Recent Developments and Future Plans
Table 59. Pharmaron Company Information, Head Office, and Major Competitors
Table 60. Pharmaron Major Business
Table 61. Pharmaron CRO in Clinical Trials Product and Solutions
Table 62. Pharmaron CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Pharmaron Recent Developments and Future Plans
Table 64. Global CRO in Clinical Trials Revenue (USD Million) by Players (2019-2024)
Table 65. Global CRO in Clinical Trials Revenue Share by Players (2019-2024)
Table 66. Breakdown of CRO in Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in CRO in Clinical Trials, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 68. Head Office of Key CRO in Clinical Trials Players
Table 69. CRO in Clinical Trials Market: Company Product Type Footprint
Table 70. CRO in Clinical Trials Market: Company Product Application Footprint
Table 71. CRO in Clinical Trials New Market Entrants and Barriers to Market Entry
Table 72. CRO in Clinical Trials Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global CRO in Clinical Trials Consumption Value (USD Million) by Type (2019-2024)
Table 74. Global CRO in Clinical Trials Consumption Value Share by Type (2019-2024)
Table 75. Global CRO in Clinical Trials Consumption Value Forecast by Type (2025-2030)
Table 76. Global CRO in Clinical Trials Consumption Value by Application (2019-2024)
Table 77. Global CRO in Clinical Trials Consumption Value Forecast by Application (2025-2030)
Table 78. North America CRO in Clinical Trials Consumption Value by Type (2019-2024) & (USD Million)
Table 79. North America CRO in Clinical Trials Consumption Value by Type (2025-2030) & (USD Million)
Table 80. North America CRO in Clinical Trials Consumption Value by Application (2019-2024) & (USD Million)
Table 81. North America CRO in Clinical Trials Consumption Value by Application (2025-2030) & (USD Million)
Table 82. North America CRO in Clinical Trials Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America CRO in Clinical Trials Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe CRO in Clinical Trials Consumption Value by Type (2019-2024) & (USD Million)
Table 85. Europe CRO in Clinical Trials Consumption Value by Type (2025-2030) & (USD Million)
Table 86. Europe CRO in Clinical Trials Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Europe CRO in Clinical Trials Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Europe CRO in Clinical Trials Consumption Value by Country (2019-2024) & (USD Million)
Table 89. Europe CRO in Clinical Trials Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2025-2030) & (USD Million)
Table 96. South America CRO in Clinical Trials Consumption Value by Type (2019-2024) & (USD Million)
Table 97. South America CRO in Clinical Trials Consumption Value by Type (2025-2030) & (USD Million)
Table 98. South America CRO in Clinical Trials Consumption Value by Application (2019-2024) & (USD Million)
Table 99. South America CRO in Clinical Trials Consumption Value by Application (2025-2030) & (USD Million)
Table 100. South America CRO in Clinical Trials Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America CRO in Clinical Trials Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2019-2024) & (USD Million)
Table 103. Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2025-2030) & (USD Million)
Table 104. Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2019-2024) & (USD Million)
Table 105. Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2025-2030) & (USD Million)
Table 106. Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2019-2024) & (USD Million)
Table 107. Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Global Key Players of CRO in Clinical Trials Upstream (Raw Materials)
Table 109. Global CRO in Clinical Trials Typical Customers
List of Figures
Figure 1. CRO in Clinical Trials Picture
Figure 2. Global CRO in Clinical Trials Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global CRO in Clinical Trials Consumption Value Market Share by Type in 2023
Figure 4. Phase I Trial
Figure 5. Phase II Trial
Figure 6. Phase III Trial
Figure 7. Phase IV Trial
Figure 8. Global CRO in Clinical Trials Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. CRO in Clinical Trials Consumption Value Market Share by Application in 2023
Figure 10. Pharmaceutical Picture
Figure 11. Bio-pharm Picture
Figure 12. Others Picture
Figure 13. Global CRO in Clinical Trials Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global CRO in Clinical Trials Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market CRO in Clinical Trials Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 16. Global CRO in Clinical Trials Consumption Value Market Share by Region (2019-2030)
Figure 17. Global CRO in Clinical Trials Consumption Value Market Share by Region in 2023
Figure 18. North America CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 21. South America CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East & Africa CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global CRO in Clinical Trials Revenue Share by Players in 2023
Figure 25. CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 26. Market Share of CRO in Clinical Trials by Player Revenue in 2023
Figure 27. Top 3 CRO in Clinical Trials Players Market Share in 2023
Figure 28. Top 6 CRO in Clinical Trials Players Market Share in 2023
Figure 29. Global CRO in Clinical Trials Consumption Value Share by Type (2019-2024)
Figure 30. Global CRO in Clinical Trials Market Share Forecast by Type (2025-2030)
Figure 31. Global CRO in Clinical Trials Consumption Value Share by Application (2019-2024)
Figure 32. Global CRO in Clinical Trials Market Share Forecast by Application (2025-2030)
Figure 33. North America CRO in Clinical Trials Consumption Value Market Share by Type (2019-2030)
Figure 34. North America CRO in Clinical Trials Consumption Value Market Share by Application (2019-2030)
Figure 35. North America CRO in Clinical Trials Consumption Value Market Share by Country (2019-2030)
Figure 36. United States CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe CRO in Clinical Trials Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe CRO in Clinical Trials Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe CRO in Clinical Trials Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 43. France CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Region (2019-2030)
Figure 50. China CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 53. India CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 56. South America CRO in Clinical Trials Consumption Value Market Share by Type (2019-2030)
Figure 57. South America CRO in Clinical Trials Consumption Value Market Share by Application (2019-2030)
Figure 58. South America CRO in Clinical Trials Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East & Africa CRO in Clinical Trials Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East & Africa CRO in Clinical Trials Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East & Africa CRO in Clinical Trials Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 67. CRO in Clinical Trials Market Drivers
Figure 68. CRO in Clinical Trials Market Restraints
Figure 69. CRO in Clinical Trials Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. CRO in Clinical Trials Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Labcorp IQVIA Parexel Syneos Health PRA Health Sciences PPD ICON Medpace Holdings Wuxi Apptec Tigermed Boji Medical Technology Pharmaron
Related Reports
18 Mar 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
